GlassScriptPhysician profile
Aracely I Ferrer
NPI 1033106893
$1,325.57
in general payments reported to CMS, 2019-2025
16 companies · $366 in 2025
The $366 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.05 · 2022: $150 · 2023: $210 · 2024: $551 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $403.28 | 2022-2025 | Azstarys |
| Vertical Pharmaceuticals, LLC | $133.96 | 2024-2025 | Relexxii |
| Pfizer INC. | $128.16 | 2019-2025 | |
| Sanofi Pasteur INC. | $123.57 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $91.70 | 2022-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Cranial Technologies, INC | $91.44 | 2022-2024 | Doc Band |
| Ironshore Pharmaceuticals INC. | $91.26 | 2024 | |
| Seqirus USA INC | $60.24 | 2024-2025 | Flucelvax |
| Noven Therapeutics, LLC | $46.56 | 2025 | Xelstrym |
| Ultragenyx Pharmaceutical INC. | $41.01 | 2024 | Crysvita |
| Alk-Abello, INC | $24.11 | 2024 | Ragwitek, Grastek, Odactra |
| Glaxosmithkline, LLC. | $21.69 | 2019 | |
| Cipher Pharmaceuticals US LLC | $21.35 | 2025 | Spinosad, Natroba |
| Cumberland Pharmaceuticals, INC. | $16.68 | 2024 | Kristalose |
| Verrica Pharmaceuticals INC. | $15.82 | 2024 | Ycanth |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $14.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aracely Ferrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.